MOURATOFF G et al. |
The effectiveness of erythromycin for the treatment of chronic genitourinary infections. |
1956-1957 |
Antibiot Annu |
pmid:13425372
|
JOHNSON SA et al. |
Clinical observations on the use of erythromycin in acne vulgaris and some pyogenic skin eruptions. |
1956-1957 |
Antibiot Annu |
pmid:13425373
|
TIDWELL RA and LEWIS D |
The use of erythromycin as a prophylactic agent. |
1956-1957 |
Antibiot Annu |
pmid:13425374
|
LEVINE ER and FROMAN A |
The efficacy of erythromycin in respiratory infections. |
1956-1957 |
Antibiot Annu |
pmid:13425495
|
FOX RT et al. |
Clinical and laboratory experiences with erythromycin in treatment of thoracic empyema. |
1955-1956 |
Antibiot Annu |
pmid:13355244
|
DAVIS DS et al. |
The treatment of one hundred and seventy-one patients with erythromycin, including one hundred and thirty-two with bacterial pneumonia. |
1955-1956 |
Antibiot Annu |
pmid:13355245
|
HAIGHT TH |
Erythromycin therapy of venereal diseases, with especial reference to the comparative use of the oral and intramuscular preparations in acute gonococcal infections. |
1955-1956 |
Antibiot Annu |
pmid:13355342
|
FRIEDMAN S et al. |
A trial of erythromycin in rheumatic fever prophylaxis. |
1957-1958 |
Antibiot Annu |
pmid:13521807
|
SHLAES WH et al. |
Antibiotic diarrhea; effect of folic acid on erythromycin-induced diarrhea. |
1957-1958 |
Antibiot Annu |
pmid:13521874
|
CALESNICK B |
Effectiveness of oral erythromycin propionate in commonly occurring infections. |
1959-1960 |
Antibiot Annu |
pmid:13806941
|
LOUGHLIN EH et al. |
Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. |
1958-1959 |
Antibiot Annu |
pmid:13637747
|
STEPHENS VC and CONINE JW |
Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. |
1958-1959 |
Antibiot Annu |
pmid:13637765
|
LEE CC et al. |
Pharmacology and toxicology of erythromycin propionate. |
1958-1959 |
Antibiot Annu |
pmid:13637766
|
GRIFFITH RS |
Laboratory and clinical studies with erythromycin propionate. |
1958-1959 |
Antibiot Annu |
pmid:13637767
|
PERRY DM et al. |
Clinical and laboratory studies of erythromycin propionate. |
1958-1959 |
Antibiot Annu |
pmid:13637768
|
KUNIN CM et al. |
Absorption of erythromycin propionate and triacetyloleandomycin. |
1958-1959 |
Antibiot Annu |
pmid:13637769
|
METZGER WI et al. |
Laboratory and clinical studies of intramuscular erythromycin. |
1958-1959 |
Antibiot Annu |
pmid:13637770
|
MARMELL M et al. |
Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. |
1959-1960 |
Antibiot Annu |
pmid:14421354
|
REICHELDERFER TE et al. |
Clinical studies of propionyl erythromycin lauryl sulfate in children. |
1959-1960 |
Antibiot Annu |
pmid:14437052
|
SALITSKY S et al. |
Erythromycin propionate: a clinical and laboratory study. |
1959-1960 |
Antibiot Annu |
pmid:14441020
|
Siegenthaler W et al. |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol]. |
1968 |
Antibiot Chemother |
pmid:4302993
|
FORFAR JO and MACCABE AF |
Erythromycin--a review. |
1957 |
Antibiot Chemother |
pmid:13488431
|
Connamacher RH |
Inducible bacterial resistance. |
1975 |
Antibiot Chemother (1971) |
pmid:773276
|
Wilson JT and van Boxtel CJ |
Pharmacokinetics of Erythromycin in man. |
1978 |
Antibiot Chemother (1971) |
pmid:27136
|
Schmid EE |
The macrolide group of antibiotics. Mode of action. |
1971 |
Antibiot Chemother (1971) |
pmid:4951002
|
Tanimoto H |
A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. |
1991 |
Antibiot Chemother (1971) |
pmid:1801651
|
WILLIAMSON GM and ZINNEMANN K |
The susceptibility of coliform bacilli to erythromycin. |
1962 |
Antibiot Chemother (Northfield) |
pmid:14007243
|
LEE CC et al. |
Further pharmacological studies on propionyl erythromycin ester lauryl sulfate. |
1961 |
Antibiot Chemother (Northfield) |
pmid:13760219
|
MANIAR AC et al. |
A comparison of the in vitro and in vivo activity of erythromycin and spiramycin. |
1960 |
Antibiot Chemother (Northfield) |
pmid:13766168
|
GRIFFITH RS |
The ratio of antimicrobial activity between propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate. |
1961 |
Antibiot Chemother (Northfield) |
pmid:13901862
|
GROGAN JB et al. |
Antibiotic susceptibility of phage type 80/81 strains of staphylococci isolated from hospital and community populations. |
1962 |
Antibiot Chemother (Northfield) |
pmid:13902091
|
CORDERO FA |
Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid. |
1961 |
Antibiot Chemother (Northfield) |
pmid:13881298
|
STROM J |
Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them. |
1961 |
Antibiot Chemother (Northfield) |
pmid:13917845
|
LIMSON BM |
Lauryl sulfate salt of propionyl erythromycin: antibacterial activity in serum and therapeutic evaluation of low doses. |
1961 |
Antibiot Chemother (Northfield) |
pmid:14465340
|
SALDANA TATE L |
In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. |
1960 |
Antibiot Chemother (Northfield) |
pmid:14440930
|
ROBINSON MM |
Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. |
1962 |
Antibiot Chemother (Northfield) |
pmid:14492925
|
KIRBY WM et al. |
Erythromycin serum concentrations following administration in acid-resistant tablets. |
1953 |
Antibiot Chemother (Northfield) |
pmid:24542409
|
KIRSHBAUM A et al. |
A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. |
1953 |
Antibiot Chemother (Northfield) |
pmid:24542421
|
GRIGSBY ME et al. |
Some laboratory and clinical experiences with erythromycin. |
1953 |
Antibiot Chemother (Northfield) |
pmid:24542704
|
HASBROUCK RB and GARVEN FC |
The chemistry of erythromycin. II. Acid degradation products. |
1953 |
Antibiot Chemother (Northfield) |
pmid:24542706
|
ANDERSON EA |
Cure of resistant meningococcemia with erythromycin. |
1953 |
Antibiot Chemother (Northfield) |
pmid:24542853
|
HAIGHT TH et al. |
Erythromycin therapy of respiratory infections. II. Effects of varying durations of therapy of streptococcal infections on eradication of streptococci and on formation of antistreptolysin O. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543018
|
LAING CR and SCOTT RB |
Erythromycin-polymyxin ointment in the treatment of pyoderma in children. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543095
|
TUNEVALL G and HEDENIUS P |
Laboratory and clinical studies with erythromycin. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543103
|
LEE CC et al. |
Site of absorption of erythromycin in rats. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543219
|
MANTEN A |
Synergism and antagonism between antibiotic mixtures containing erythromycin. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543317
|
KUZEL NR et al. |
Spectrophotometric determination of erythromycin in pharmaceutical products. |
1954 |
Antibiot Chemother (Northfield) |
pmid:24543318
|
CLARK RK and TATERKA M |
The chemistry of erythromycin. III. Acid degradation products of erythromycin B. |
1955 |
Antibiot Chemother (Northfield) |
pmid:24543468
|
CLARK RK and FREIFELDER M |
The synthesis of new erythromycins. |
1957 |
Antibiot Chemother (Northfield) |
pmid:24544531
|
CLARK RK and VARNER EL |
New esters of erythromycin. |
1957 |
Antibiot Chemother (Northfield) |
pmid:24544532
|